Patient Support Technology Market Size, Share & Trends Analysis Report By Type (Standalone, Integrated), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Patient Support Technology Market Growth & Trends
The global patient support technology market is expected to reach USD 3.2 billion by 2030, registering a CAGR of 10.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing requirement for comprehensive patient-centric solutions, increasing adoption of digital healthcare solutions by healthcare systems, technological advancements, and active participation in strategic advancements by the market players are expected to drive market growth.
Furthermore, mobile health applications or mHealth apps are playing a crucial role in accelerating the growth of the patient support technology market. These applications provide diverse functionalities, including medication reminders, health monitoring, symptom tracking, and virtual consultations. They encourage patients by enabling active engagement in their healthcare management, promoting healthy habits, and facilitating seamless communication with healthcare providers. The rising use of smartphones and wearable devices amplifies the adoption of mHealth apps, solidifying their position as an essential component of the patient support technology ecosystem.
According to IQVIA, companies seeking optimal outcomes for stakeholders should align their investment strategy in Patient Support Program (PSP) technology with the EESI (EASY) goals. These objectives emphasize enhancing patient and care partner engagement, fostering collaboration among service teams, simplifying user experiences, and enhancing insight generation for improved patient outcomes. This alignment involves promoting active participation, effective communication, and shared decision-making among patients and their care partners, facilitating seamless teamwork and communication across service teams, designing intuitive interfaces for enhanced usability, and leveraging data-driven approaches to derive actionable insights and streamline workflows. By integrating their PSP technology investment strategy with the EESI (EASY) goals, companies can elevate patient engagement, enhance team collaboration, streamline user experiences, and drive better patient outcomes.
Furthermore, technology offers the potential to enhance program performance measurement, enabling the incorporation of practical assessments into patient outcomes. This technology is utilized to conduct thorough investigations into longitudinal performance, aiding in evaluating patient outcomes during therapy over extended periods. Furthermore, AI and machine learning-driven technology platforms analyze patients' diverse needs, enabling a more customized and personalized experience. Integrating innovative technologies across different stages of the patient support lifecycle presents an opportunity to gain comprehensive insights into patient needs through data and advanced analytics.
In September 2023, Microsoft Corp. and Mercy partnered to utilize generative AI and digital technologies, enabling healthcare providers to devote more time to patient care and enhance the patient experience. Generative AI-assisted communication empowers patients by providing understandable lab results and facilitating informed discussions. Additionally, the chatbot aids Mercy co-workers in swiftly accessing essential information, allowing nurses and staff to focus more on patient care.
Patient Support Technology Market Report Highlights
Patient Support Technology Market Growth & Trends
The global patient support technology market is expected to reach USD 3.2 billion by 2030, registering a CAGR of 10.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing requirement for comprehensive patient-centric solutions, increasing adoption of digital healthcare solutions by healthcare systems, technological advancements, and active participation in strategic advancements by the market players are expected to drive market growth.
Furthermore, mobile health applications or mHealth apps are playing a crucial role in accelerating the growth of the patient support technology market. These applications provide diverse functionalities, including medication reminders, health monitoring, symptom tracking, and virtual consultations. They encourage patients by enabling active engagement in their healthcare management, promoting healthy habits, and facilitating seamless communication with healthcare providers. The rising use of smartphones and wearable devices amplifies the adoption of mHealth apps, solidifying their position as an essential component of the patient support technology ecosystem.
According to IQVIA, companies seeking optimal outcomes for stakeholders should align their investment strategy in Patient Support Program (PSP) technology with the EESI (EASY) goals. These objectives emphasize enhancing patient and care partner engagement, fostering collaboration among service teams, simplifying user experiences, and enhancing insight generation for improved patient outcomes. This alignment involves promoting active participation, effective communication, and shared decision-making among patients and their care partners, facilitating seamless teamwork and communication across service teams, designing intuitive interfaces for enhanced usability, and leveraging data-driven approaches to derive actionable insights and streamline workflows. By integrating their PSP technology investment strategy with the EESI (EASY) goals, companies can elevate patient engagement, enhance team collaboration, streamline user experiences, and drive better patient outcomes.
Furthermore, technology offers the potential to enhance program performance measurement, enabling the incorporation of practical assessments into patient outcomes. This technology is utilized to conduct thorough investigations into longitudinal performance, aiding in evaluating patient outcomes during therapy over extended periods. Furthermore, AI and machine learning-driven technology platforms analyze patients' diverse needs, enabling a more customized and personalized experience. Integrating innovative technologies across different stages of the patient support lifecycle presents an opportunity to gain comprehensive insights into patient needs through data and advanced analytics.
In September 2023, Microsoft Corp. and Mercy partnered to utilize generative AI and digital technologies, enabling healthcare providers to devote more time to patient care and enhance the patient experience. Generative AI-assisted communication empowers patients by providing understandable lab results and facilitating informed discussions. Additionally, the chatbot aids Mercy co-workers in swiftly accessing essential information, allowing nurses and staff to focus more on patient care.
Patient Support Technology Market Report Highlights
- Based on type, the integrated segment dominated the market in 2023, owing to the availability of a comprehensive solution and increased focus on patient-centered care.
- North America dominated the global market with a revenue share of 41.12% in 2023. The growth is attributed to the increasing government initiative, technological advancement in the healthcare industry, and a strong presence of key market players.
- The patient support technology market is competitive, and various players are adopting strategies such as new product launches, partnerships, and acquisitions to strengthen their market share. For instance, in October 2023, ZS launched the AI-powered ZAIDYN Connected Health solution, part of the ZAIDYN by ZS platform. ZAIDYN Connected Health helps pharmaceutical companies, healthcare providers, and payers innovate to understand unmet needs, better engage with patients, and improve health outcomes.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Regional outlook
2.3. Competitive Insights
CHAPTER 3. PATIENT SUPPORT TECHNOLOGY MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Patient Support Technology Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & legal landscape
3.3.2.2. Economic landscape
3.3.2.3. Social & environmental landscape
3.3.2.4. Technological landscape
3.3.3. Impact of COVID-19
CHAPTER 4. PATIENT SUPPORT TECHNOLOGY MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Patient Support Technology Market by Type Outlook
4.4. Standalone
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Integrated
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. PATIENT SUPPORT TECHNOLOGY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE
5.1. Regional Market Share Analysis, 2023 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
5.5. North America
5.5.1. U.S.
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Canada
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Europe
5.6.1. UK
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Germany
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. France
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.6.4. Italy
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.6.5. Spain
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework/ reimbursement structure
5.6.5.3. Competitive scenario
5.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.6.6. Denmark
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework/ reimbursement structure
5.6.6.3. Competitive scenario
5.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.6.7. Sweden
5.6.7.1. Key country dynamics
5.6.7.2. Regulatory framework/ reimbursement structure
5.6.7.3. Competitive scenario
5.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
5.6.8. Norway
5.6.8.1. Key country dynamics
5.6.8.2. Regulatory framework/ reimbursement structure
5.6.8.3. Competitive scenario
5.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Asia Pacific
5.7.1. Japan
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. China
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
5.7.3. India
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
5.7.4. Australia
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
5.7.5. South Korea
5.7.5.1. Key country dynamics
5.7.5.2. Regulatory framework/ reimbursement structure
5.7.5.3. Competitive scenario
5.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
5.7.6. Thailand
5.7.6.1. Key country dynamics
5.7.6.2. Regulatory framework/ reimbursement structure
5.7.6.3. Competitive scenario
5.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Latin America
5.8.1. Brazil
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework/ reimbursement structure
5.8.1.3. Competitive scenario
5.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
5.8.2. Mexico
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework/ reimbursement structure
5.8.2.3. Competitive scenario
5.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
5.8.3. Argentina
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework/ reimbursement structure
5.8.3.3. Competitive scenario
5.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
5.9. MEA
5.9.1. South Africa
5.9.1.1. Key country dynamics
5.9.1.2. Regulatory framework/ reimbursement structure
5.9.1.3. Competitive scenario
5.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
5.9.2. Saudi Arabia
5.9.2.1. Key country dynamics
5.9.2.2. Regulatory framework/ reimbursement structure
5.9.2.3. Competitive scenario
5.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
5.9.3. UAE
5.9.3.1. Key country dynamics
5.9.3.2. Regulatory framework/ reimbursement structure
5.9.3.3. Competitive scenario
5.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
5.9.4. Kuwait
5.9.4.1. Key country dynamics
5.9.4.2. Regulatory framework/ reimbursement structure
5.9.4.3. Competitive scenario
5.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.2.2. List of key distributors and channel partners
6.2.3. Key customers
6.2.4. Key company market share analysis, 2023
6.2.5. Deloitte
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Accenture
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. McKesson Corporation
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Cardinal Health
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. DataRiver S.r.l
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Medisafe
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. Inizio Engage
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. AssistRx
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Regional outlook
2.3. Competitive Insights
CHAPTER 3. PATIENT SUPPORT TECHNOLOGY MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Patient Support Technology Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & legal landscape
3.3.2.2. Economic landscape
3.3.2.3. Social & environmental landscape
3.3.2.4. Technological landscape
3.3.3. Impact of COVID-19
CHAPTER 4. PATIENT SUPPORT TECHNOLOGY MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Patient Support Technology Market by Type Outlook
4.4. Standalone
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Integrated
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. PATIENT SUPPORT TECHNOLOGY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE
5.1. Regional Market Share Analysis, 2023 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
5.5. North America
5.5.1. U.S.
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Canada
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Europe
5.6.1. UK
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Germany
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. France
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.6.4. Italy
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.6.5. Spain
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework/ reimbursement structure
5.6.5.3. Competitive scenario
5.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.6.6. Denmark
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework/ reimbursement structure
5.6.6.3. Competitive scenario
5.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.6.7. Sweden
5.6.7.1. Key country dynamics
5.6.7.2. Regulatory framework/ reimbursement structure
5.6.7.3. Competitive scenario
5.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
5.6.8. Norway
5.6.8.1. Key country dynamics
5.6.8.2. Regulatory framework/ reimbursement structure
5.6.8.3. Competitive scenario
5.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Asia Pacific
5.7.1. Japan
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. China
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
5.7.3. India
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
5.7.4. Australia
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
5.7.5. South Korea
5.7.5.1. Key country dynamics
5.7.5.2. Regulatory framework/ reimbursement structure
5.7.5.3. Competitive scenario
5.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
5.7.6. Thailand
5.7.6.1. Key country dynamics
5.7.6.2. Regulatory framework/ reimbursement structure
5.7.6.3. Competitive scenario
5.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Latin America
5.8.1. Brazil
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework/ reimbursement structure
5.8.1.3. Competitive scenario
5.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
5.8.2. Mexico
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework/ reimbursement structure
5.8.2.3. Competitive scenario
5.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
5.8.3. Argentina
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework/ reimbursement structure
5.8.3.3. Competitive scenario
5.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
5.9. MEA
5.9.1. South Africa
5.9.1.1. Key country dynamics
5.9.1.2. Regulatory framework/ reimbursement structure
5.9.1.3. Competitive scenario
5.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
5.9.2. Saudi Arabia
5.9.2.1. Key country dynamics
5.9.2.2. Regulatory framework/ reimbursement structure
5.9.2.3. Competitive scenario
5.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
5.9.3. UAE
5.9.3.1. Key country dynamics
5.9.3.2. Regulatory framework/ reimbursement structure
5.9.3.3. Competitive scenario
5.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
5.9.4. Kuwait
5.9.4.1. Key country dynamics
5.9.4.2. Regulatory framework/ reimbursement structure
5.9.4.3. Competitive scenario
5.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.2.2. List of key distributors and channel partners
6.2.3. Key customers
6.2.4. Key company market share analysis, 2023
6.2.5. Deloitte
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Accenture
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. McKesson Corporation
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Cardinal Health
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. DataRiver S.r.l
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Medisafe
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. Inizio Engage
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. AssistRx
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 North America patient support technology market, by region, 2018 - 2030 (USD Million)
Table 3 North America patient support technology market, by type, 2018 - 2030 (USD Million)
Table 4 U.S. patient support technology market, by type, 2018 - 2030 (USD Million)
Table 5 Canada patient support technology market, by type, 2018 - 2030 (USD Million)
Table 6 Europe patient support technology market, by region, 2018 - 2030 (USD Million)
Table 7 Europe patient support technology market, by type, 2018 - 2030 (USD Million)
Table 8 Germany patient support technology market, by type, 2018 - 2030 (USD Million)
Table 9 UK patient support technology market, by type, 2018 - 2030 (USD Million)
Table 10 France patient support technology market, by type, 2018 - 2030 (USD Million)
Table 11 Italy patient support technology market, by type, 2018 - 2030 (USD Million)
Table 12 Spain patient support technology market, by type, 2018 - 2030 (USD Million)
Table 13 Denmark patient support technology market, by type, 2018 - 2030 (USD Million)
Table 14 Sweden patient support technology market, by type, 2018 - 2030 (USD Million)
Table 15 Norway patient support technology market, by type, 2018 - 2030 (USD Million)
Table 16 Asia Pacific patient support technology market, by region, 2018 - 2030 (USD Million)
Table 17 Asia Pacific patient support technology market, by type, 2018 - 2030 (USD Million)
Table 18 China patient support technology market, by type, 2018 - 2030 (USD Million)
Table 19 Japan patient support technology market, by type, 2018 - 2030 (USD Million)
Table 20 India patient support technology market, by type, 2018 - 2030 (USD Million)
Table 21 South Korea patient support technology market, by type, 2018 - 2030 (USD Million)
Table 22 Australia patient support technology market, by type, 2018 - 2030 (USD Million)
Table 23 Thailand patient support technology market, by type, 2018 - 2030 (USD Million)
Table 24 Latin America patient support technology market, by region, 2018 - 2030 (USD Million)
Table 25 Latin America patient support technology market, by type, 2018 - 2030 (USD Million)
Table 26 Brazil patient support technology market, by type, 2018 - 2030 (USD Million)
Table 27 Mexico patient support technology market, by type, 2018 - 2030 (USD Million)
Table 28 Argentina patient support technology market, by type, 2018 - 2030 (USD Million)
Table 29 MEA patient support technology market, by region, 2018 - 2030 (USD Million)
Table 30 MEA patient support technology market, by type, 2018 - 2030 (USD Million)
Table 31 South Africa patient support technology market, by type, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia patient support technology market, by type, 2018 - 2030 (USD Million)
Table 33 UAE patient support technology market, by type, 2018 - 2030 (USD Million)
Table 34 Kuwait patient support technology market, by type, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 North America patient support technology market, by region, 2018 - 2030 (USD Million)
Table 3 North America patient support technology market, by type, 2018 - 2030 (USD Million)
Table 4 U.S. patient support technology market, by type, 2018 - 2030 (USD Million)
Table 5 Canada patient support technology market, by type, 2018 - 2030 (USD Million)
Table 6 Europe patient support technology market, by region, 2018 - 2030 (USD Million)
Table 7 Europe patient support technology market, by type, 2018 - 2030 (USD Million)
Table 8 Germany patient support technology market, by type, 2018 - 2030 (USD Million)
Table 9 UK patient support technology market, by type, 2018 - 2030 (USD Million)
Table 10 France patient support technology market, by type, 2018 - 2030 (USD Million)
Table 11 Italy patient support technology market, by type, 2018 - 2030 (USD Million)
Table 12 Spain patient support technology market, by type, 2018 - 2030 (USD Million)
Table 13 Denmark patient support technology market, by type, 2018 - 2030 (USD Million)
Table 14 Sweden patient support technology market, by type, 2018 - 2030 (USD Million)
Table 15 Norway patient support technology market, by type, 2018 - 2030 (USD Million)
Table 16 Asia Pacific patient support technology market, by region, 2018 - 2030 (USD Million)
Table 17 Asia Pacific patient support technology market, by type, 2018 - 2030 (USD Million)
Table 18 China patient support technology market, by type, 2018 - 2030 (USD Million)
Table 19 Japan patient support technology market, by type, 2018 - 2030 (USD Million)
Table 20 India patient support technology market, by type, 2018 - 2030 (USD Million)
Table 21 South Korea patient support technology market, by type, 2018 - 2030 (USD Million)
Table 22 Australia patient support technology market, by type, 2018 - 2030 (USD Million)
Table 23 Thailand patient support technology market, by type, 2018 - 2030 (USD Million)
Table 24 Latin America patient support technology market, by region, 2018 - 2030 (USD Million)
Table 25 Latin America patient support technology market, by type, 2018 - 2030 (USD Million)
Table 26 Brazil patient support technology market, by type, 2018 - 2030 (USD Million)
Table 27 Mexico patient support technology market, by type, 2018 - 2030 (USD Million)
Table 28 Argentina patient support technology market, by type, 2018 - 2030 (USD Million)
Table 29 MEA patient support technology market, by region, 2018 - 2030 (USD Million)
Table 30 MEA patient support technology market, by type, 2018 - 2030 (USD Million)
Table 31 South Africa patient support technology market, by type, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia patient support technology market, by type, 2018 - 2030 (USD Million)
Table 33 UAE patient support technology market, by type, 2018 - 2030 (USD Million)
Table 34 Kuwait patient support technology market, by type, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Patient support technology market: market outlook
Fig. 9 Patient support technology competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Patient support technology market driver impact
Fig. 15 Patient support technology market restraint impact
Fig. 16 Patient support technology market strategic initiatives analysis
Fig. 17 Patient support technology market: Type movement analysis
Fig. 18 Patient support technology market: Type outlook and key takeaways
Fig. 19 Standalone market estimates and forecast, 2018 - 2030
Fig. 20 Integrated market estimates and forecast, 2018 - 2030
Fig. 21 Global patient support technology market: Regional movement analysis
Fig. 22 Global patient support technology market: Regional outlook and key takeaways
Fig. 23 Global patient support technology market share and leading players
Fig. 24 North America market share and leading players
Fig. 25 Europe market share and leading players
Fig. 26 Asia Pacific market share and leading players
Fig. 27 Latin America market share and leading players
Fig. 28 Middle East & Africa market share and leading players
Fig. 29 North America: SWOT
Fig. 30 Europe SWOT
Fig. 31 Asia Pacific SWOT
Fig. 32 Latin America SWOT
Fig. 33 MEA SWOT
Fig. 34 North America market estimates and forecasts, 2018 - 2030
Fig. 35 U.S. key country dynamics
Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
Fig. 37 Canada key country dynamics
Fig. 38 Canada market estimates and forecasts, 2018 - 2030
Fig. 39 Europe market estimates and forecasts, 2018 - 2030
Fig. 40 UK key country dynamics
Fig. 41 UK market estimates and forecasts, 2018 - 2030
Fig. 42 Germany key country dynamics
Fig. 43 Germany market estimates and forecasts, 2018 - 2030
Fig. 44 France key country dynamics
Fig. 45 France market estimates and forecasts, 2018 - 2030
Fig. 46 Italy key country dynamics
Fig. 47 Italy market estimates and forecasts, 2018 - 2030
Fig. 48 Spain key country dynamics
Fig. 49 Spain market estimates and forecasts, 2018 - 2030
Fig. 50 Denmark key country dynamics
Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
Fig. 52 Sweden key country dynamics
Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
Fig. 54 Norway key country dynamics
Fig. 55 Norway market estimates and forecasts, 2018 - 2030
Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 57 China key country dynamics
Fig. 58 China market estimates and forecasts, 2018 - 2030
Fig. 59 Japan key country dynamics
Fig. 60 Japan market estimates and forecasts, 2018 - 2030
Fig. 61 India key country dynamics
Fig. 62 India market estimates and forecasts, 2018 - 2030
Fig. 63 Thailand key country dynamics
Fig. 64 Thailand market estimates and forecasts, 2018 - 2030
Fig. 65 South Korea key country dynamics
Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
Fig. 67 Australia key country dynamics
Fig. 68 Australia market estimates and forecasts, 2018 - 2030
Fig. 69 Latin America market estimates and forecasts, 2018 - 2030
Fig. 70 Brazil key country dynamics
Fig. 71 Brazil market estimates and forecasts, 2018 - 2030
Fig. 72 Mexico key country dynamics
Fig. 73 Mexico market estimates and forecasts, 2018 - 2030
Fig. 74 Argentina key country dynamics
Fig. 75 Argentina market estimates and forecasts, 2018 - 2030
Fig. 76 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 77 South Africa key country dynamics
Fig. 78 South Africa market estimates and forecasts, 2018 - 2030
Fig. 79 Saudi Arabia key country dynamics
Fig. 80 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 81 UAE key country dynamics
Fig. 82 UAE market estimates and forecasts, 2018 - 2030
Fig. 83 Kuwait key country dynamics
Fig. 84 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 85 Key company categorization
Fig. 86 Company market position analysis, 2023
Fig. 87 Strategy mapping
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Patient support technology market: market outlook
Fig. 9 Patient support technology competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Patient support technology market driver impact
Fig. 15 Patient support technology market restraint impact
Fig. 16 Patient support technology market strategic initiatives analysis
Fig. 17 Patient support technology market: Type movement analysis
Fig. 18 Patient support technology market: Type outlook and key takeaways
Fig. 19 Standalone market estimates and forecast, 2018 - 2030
Fig. 20 Integrated market estimates and forecast, 2018 - 2030
Fig. 21 Global patient support technology market: Regional movement analysis
Fig. 22 Global patient support technology market: Regional outlook and key takeaways
Fig. 23 Global patient support technology market share and leading players
Fig. 24 North America market share and leading players
Fig. 25 Europe market share and leading players
Fig. 26 Asia Pacific market share and leading players
Fig. 27 Latin America market share and leading players
Fig. 28 Middle East & Africa market share and leading players
Fig. 29 North America: SWOT
Fig. 30 Europe SWOT
Fig. 31 Asia Pacific SWOT
Fig. 32 Latin America SWOT
Fig. 33 MEA SWOT
Fig. 34 North America market estimates and forecasts, 2018 - 2030
Fig. 35 U.S. key country dynamics
Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
Fig. 37 Canada key country dynamics
Fig. 38 Canada market estimates and forecasts, 2018 - 2030
Fig. 39 Europe market estimates and forecasts, 2018 - 2030
Fig. 40 UK key country dynamics
Fig. 41 UK market estimates and forecasts, 2018 - 2030
Fig. 42 Germany key country dynamics
Fig. 43 Germany market estimates and forecasts, 2018 - 2030
Fig. 44 France key country dynamics
Fig. 45 France market estimates and forecasts, 2018 - 2030
Fig. 46 Italy key country dynamics
Fig. 47 Italy market estimates and forecasts, 2018 - 2030
Fig. 48 Spain key country dynamics
Fig. 49 Spain market estimates and forecasts, 2018 - 2030
Fig. 50 Denmark key country dynamics
Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
Fig. 52 Sweden key country dynamics
Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
Fig. 54 Norway key country dynamics
Fig. 55 Norway market estimates and forecasts, 2018 - 2030
Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 57 China key country dynamics
Fig. 58 China market estimates and forecasts, 2018 - 2030
Fig. 59 Japan key country dynamics
Fig. 60 Japan market estimates and forecasts, 2018 - 2030
Fig. 61 India key country dynamics
Fig. 62 India market estimates and forecasts, 2018 - 2030
Fig. 63 Thailand key country dynamics
Fig. 64 Thailand market estimates and forecasts, 2018 - 2030
Fig. 65 South Korea key country dynamics
Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
Fig. 67 Australia key country dynamics
Fig. 68 Australia market estimates and forecasts, 2018 - 2030
Fig. 69 Latin America market estimates and forecasts, 2018 - 2030
Fig. 70 Brazil key country dynamics
Fig. 71 Brazil market estimates and forecasts, 2018 - 2030
Fig. 72 Mexico key country dynamics
Fig. 73 Mexico market estimates and forecasts, 2018 - 2030
Fig. 74 Argentina key country dynamics
Fig. 75 Argentina market estimates and forecasts, 2018 - 2030
Fig. 76 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 77 South Africa key country dynamics
Fig. 78 South Africa market estimates and forecasts, 2018 - 2030
Fig. 79 Saudi Arabia key country dynamics
Fig. 80 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 81 UAE key country dynamics
Fig. 82 UAE market estimates and forecasts, 2018 - 2030
Fig. 83 Kuwait key country dynamics
Fig. 84 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 85 Key company categorization
Fig. 86 Company market position analysis, 2023
Fig. 87 Strategy mapping
